Ulf Grawunder

Ulf Grawunder was the founder of 4-Antibody AG, founded in 2002, where he held the title of Chief Scientist from 2009 to 2010.
He is also the founder of NBE-Therapeutics AG, founded in 2012, where he currently holds the title of Director, Chief Operating & Development Officer.
Additionally, Dr. Grawunder is the founder of T-CURX GmbH, founded in 2022, where he currently serves as the Chief Executive Officer.
Dr. Grawunder's current job(s) include being an Independent Non-Executive Director at WuXi XDC Cayman, Inc., an Independent Director at Adagene, Inc., and the Managing Partner at Viopas Venture Consulting GmbH.
Dr. Grawunder's former job includes being a Principal at the University of Southern California.
In terms of education, Dr. Grawunder obtained a doctorate degree from the University of Basel in 1994 and a graduate degree from the University of Bayreuth in 1991.